AstraZeneca have filed an European marketing authorization application for gefitinib (Iressa) as a treatment for locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC).
Filed under: kinase | Tagged: AstraZeneca, EGF kinase, gefitinib, Iressa, kinase | Leave a Comment »
